ADIPOQ and metabolic syndrome: The difference of adiponectin levels between cases of IHD and their controls retained statistical significance at multivariate analysis after adjustment for components of the metabolic syndrome, with an increased risk of IHD of 61% (2–161) (P < 0.05) for each decrement of 1 μg/mL.